RFK Jr. Orders Mifepristone Review Amidst Anti-Abortion Push
US Health Secretary Robert F. Kennedy Jr. has directed the FDA to review mifepristone regulations based on new data from a flawed, non-peer-reviewed analysis. This analysis, promoted by anti-abortion groups, alleges higher complication rates than previously known, prompting calls to reinstate prior restrictions or remove the drug entirely. The data significantly overstates risks, including misclassifying ectopic pregnancies as complications of mifepristone. Anti-abortion groups intend to use this analysis to pressure the FDA and lawmakers to severely limit mifepristone access, potentially through ending telemedicine prescriptions as a first step. Despite over 100 studies confirming mifepristone’s safety and effectiveness, this campaign aims to significantly restrict access to the abortion pill.
John Q. Hosedrinker